UNSPSC 41141821: Low density lipoprotein cholesterol including sd-ldl

In this classification, this entry connotes a substrate made of Low density lipoprotein cholesterol including sd-ldl that is used in clinical chemistry testing.

UNSPSC 41141821 Low density lipoprotein cholesterol including sd-ldL is a Commodity code that does not map to the recent state and local contract opportunities in the dataset. The opportunities posted under this code span laboratory supplies, reagents, and consumables for public health testing — including drug-testing analyzer supplies, food and water safety reagents, wastewater surveillance kits, culture media, solid phase extraction disks, chromatography standards, and whole genome sequencing reagents — none of which relates to lipid panel testing or cholesterol measurement. The code's nominal scope (clinical laboratory measurement of low-density lipoprotein cholesterol and its subtypes) diverges substantially from the actual work state and local health departments are purchasing under this classification. The mismatch suggests either a cataloging error in the source data or a systematic miscoding of laboratory consumables within this UNSPSC category.

The issuing bodies include state health departments (Texas HHSC/DSHS, Mississippi State Department of Health), county health departments (Gwinnett County, Georgia), a municipal procurement office (City of Philadelphia), and an academic health system (University of Texas Health Science Center at San Antonio). Geographic activity concentrates in Texas and Mississippi, with isolated activity in Georgia and Pennsylvania. Representative recent opportunities include the Texas HHSC/DSHS IFB HHS0017272 for respiratory pathogen detection kits for wastewater surveillance (bid deadline May 19, 2026), the Mississippi State Department of Health sole-source procurement for Illumina whole genome sequencing kits and reagents (objections deadline May 14, 2026, estimated cost $393,667.98), and the Mississippi State Department of Health sole-source procurement for EPA and FDA-approved Colilert and Colisure reagents for coliform testing in drinking water and dairy water (objections deadline August 24, 2026, estimated cost $338,861.98).